Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions

被引：0
|
作者：
Megan Sears-Smith
Thomas G. Knight
机构：
[1] Levine Cancer Institute,
[2] Atrium Health,undefined
[3] Levine Cancer Institute,undefined
[4] Atrium Health,undefined
来源：
Current Hematologic Malignancy Reports | 2023年 / 18卷
关键词：
Financial stress; Disparities; Economic burden; Healthcare costs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：158 / 166
页数：8
相关论文
共 50 条
  • [31] Estimating financial toxicity in patients with gynecological malignancies undergoing chemotherapy
    Chatterjee, S.
    Gabor, L.
    Jones, N. L.
    Buskwofie, A.
    Burke, W. M.
    Hou, J. Y.
    Tergas, A. I.
    Wright, J. D.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 175 - 175
  • [32] Financial toxicity in patients with gynecologic malignancies: a cross sectional study
    Zeybek, Burak
    Webster, Emily
    Pogosian, Natalia
    Tymon-Rosario, Joan
    Balch, Alan
    Altwerger, Gary
    Clark, Mitchell
    Menderes, Gulden
    Huang, Gloria
    Azodi, Masoud
    Ratner, Elena S.
    Schwartz, Peter E.
    Santin, Alessandro D.
    Andikyan, Vaagn
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (06) : e87
  • [33] The Effect of Coping Interventions on Fatigue in Persons with Hematologic Malignancies: A Systematic Review and Narrative Synthesis
    Andersen, Lucy
    Ulrich, Connie
    Meghani, Salimah
    Deng, Jie
    NURSING RESEARCH, 2022, 71 (03) : S46 - S46
  • [34] Financial Toxicity Intervention Improves Quality of Life in Hematologic Malignancy Patients
    Knight, Thomas G.
    Aguiar, Melissa
    Robinson, Myra
    Martin, Allison
    Cranford, Heather
    Chen, Tommy
    Bose, Rupali
    Ai, Jing
    Ragon, Brittany K.
    Chojecki, Aleksander L.
    Shah, Nilay A.
    Sanikommu, Srinivasa R.
    Symanowski, James
    Copelan, Edward A.
    Grunwald, Michael R.
    BLOOD, 2020, 136
  • [35] A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx
    Amaeshi, Lemchukwu
    Sisto, Alex
    Laufer, Lauren
    Fedorov, Kateryna
    Mathew, Rosmi
    Levitz, David
    Mantzaris, Ioannis
    Kornblum, Noah
    Goldfinger, Mendel
    Sica, Alejandro
    Cooper, Dennis L.
    Konopleva, Marina Y.
    Rapkin, Bruce
    Verma, Amit
    Shastri, Aditi
    Shah, Nishi
    BLOOD, 2023, 142
  • [36] Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies
    DeMagalhaesSilverman, M
    Bloom, EJ
    Donnenberg, A
    Lister, J
    Pincus, S
    Rybka, WB
    Ball, ED
    BONE MARROW TRANSPLANTATION, 1996, 17 (03) : 329 - 333
  • [37] Interventions for financial toxicity among cancer survivors: A scoping review
    Yuan, Xiaoyi
    Zhang, Xuehui
    He, Jing
    Xing, Weijie
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 192
  • [38] STRONGYLOIDIASIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    NUCCI, M
    PORTUGAL, R
    PULCHERI, W
    SPECTOR, N
    FERREIRA, SB
    DECASTRO, MB
    NOE, R
    DEOLIVEIRA, HP
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) : 675 - 677
  • [39] CRYPTOSPORIDIOSIS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    GENTILE, G
    VENDITTI, M
    MICOZZI, A
    CAPRIOLI, A
    DONELLI, G
    TIRINDELLI, C
    MELONI, G
    ARCESE, W
    MARTINO, P
    REVIEWS OF INFECTIOUS DISEASES, 1991, 13 (05): : 842 - 846
  • [40] Angiogenesis in patients with hematologic malignancies
    Mesters, RM
    Padró, T
    Steins, M
    Bieker, R
    Retzlaff, S
    Kessler, T
    Kienast, J
    Berdel, WE
    ONKOLOGIE, 2001, 24 : 75 - 80
12345